
The research will compare the experiences of neurodivergent and neurotypical women at different stages of the menopausal transition

Israeli researchers tested the new drug and achieved a survival rate of 80 per cent

The submission is supported by data from more than 700 breast cancer patients across five clinical studies

By Leigh Coggiola-Belza, founder and CEO at Leaxy

97% of women felt they did not have all the information needed when first considering treatment

The company has partnered with the renowned American neuroscientist to help members better manage physiological stress

The new platform aims to personalise user experience and meet women's health and wellbeing goals

By Lauren Elliott, founder and CEO of Candlelit Care

CRGH Insight will utilise Fairtility’s explainable AI for embryo quality analysis, offering transparency to IVF professionals and patients

One start-up will be selected to receive marketing services, mentorship, and networking opportunities through RAPP